A randomized clinical trial of app cognitive behavior therapy vs. HealthWatch for obsessive compulsive disorder.

Sabine Wilhelm¹, Jennifer L Greenberg², Ryan J Jacoby², Hilary Weingarden², Susanne S Hoeppner², Dalton Klare², Ivar Snorrason², Adam C Jaroszewski², Thomas H McCoy², Oliver Harrison³

¹Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. swilhelm@mgh.harvard.edu.

²Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

³Koa Health, London, UK.

PubMed PMC DOI PDF

Abstract

App-based cognitive behavioral therapy (app-CBT) addresses many treatment barriers. We randomized 120 U.S. adults with primary OCD (82.4% female, 77.5% White, mean age 40.1) between 7/2021 and 7/2023 to 12-weeks of coach-guided Perspectives (n = 60; app-CBT) or coach-guided HealthWatch (n = 60; an online well-being program). OCD severity (Yale-Brown Obsessive Compulsive Scale; primary outcome) ana…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.